Robert LeBoyer
Stock Analyst at Noble Financial
(0.04)
# 4,770
Out of 5,043 analysts
430
Total ratings
27.1%
Success rate
-13%
Average return
Main Sectors:
Stocks Rated by Robert LeBoyer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCGN Ocugen | Reiterated: Buy | $12 | $0.9555 | +1,155.89% | 45 | Sep 28, 2026 | |
| NNVC NanoViricides | Reiterated: Buy | $6 | $1.30 | +361.54% | 4 | Sep 24, 2026 | |
| ELDN Eledon Pharmaceuticals | Reiterated: Buy | $10 | $2.48 | +303.23% | 24 | Sep 23, 2026 | |
| MAIA MAIA Biotechnology | Reiterated: Buy | $14 | $1.22 | +1,047.54% | 24 | Sep 22, 2026 | |
| GOVX GeoVax Labs | Reiterated: Buy | $10 | $0.281 | +3,458.72% | 27 | Sep 17, 2026 | |
| UNCY Unicycive Therapeutics | Reiterated: Buy | $50 | $4.11 | +1,116.55% | 20 | Aug 13, 2026 | |
| NTRB Nutriband | Reiterated: Buy | $15 | $6.65 | +125.56% | 10 | Aug 12, 2026 | |
| NRSN NeuroSense Therapeutics | Reiterated: Buy | $180 | $3.66 | +4,818.03% | 8 | Aug 11, 2026 | |
| GYRE Gyre Therapeutics | Reiterated: Buy | $20 | $7.04 | +184.09% | 11 | Aug 10, 2026 | |
| CVKD Cadrenal Therapeutics | Reiterated: Buy | $45 | $0.9101 | +4,844.51% | 17 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $16.53 | +172.23% | 9 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $10 | $1.07 | +834.58% | 28 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $1.08 | +1,011.11% | 5 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $6.63 | +20.66% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $37 | $7.30 | +406.85% | 30 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.082515 | n/a | 5 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.38 | n/a | 36 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.4452 | n/a | 24 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.079875 | n/a | 3 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.72 | n/a | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $0.994 | n/a | 11 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.72 | $0.04 | n/a | 2 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $20 | $1.49 | n/a | 10 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $27 | $0.000001 | n/a | 7 | Feb 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $15 | $4.33 | n/a | 8 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.93 | n/a | 1 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $14 | $1.55 | n/a | 7 | Jan 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.35 | n/a | 2 | Dec 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.5989 | n/a | 6 | Dec 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.000001 | n/a | 5 | Nov 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.87 | n/a | 1 | Oct 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $4.79 | n/a | 8 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $1.41 | n/a | 1 | Feb 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.51 | n/a | 2 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.08 | n/a | 2 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $17 → $1 | $31.18 | n/a | 2 | Apr 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.38 | n/a | 3 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.96 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.06 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.87 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 4 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $54 → $41 | $19.78 | n/a | 2 | Aug 5, 2016 |
Ocugen
Sep 28, 2026
Reiterated: Buy
Price Target: $12
Current: $0.9555
Upside: +1,155.89%
NanoViricides
Sep 24, 2026
Reiterated: Buy
Price Target: $6
Current: $1.30
Upside: +361.54%
Eledon Pharmaceuticals
Sep 23, 2026
Reiterated: Buy
Price Target: $10
Current: $2.48
Upside: +303.23%
MAIA Biotechnology
Sep 22, 2026
Reiterated: Buy
Price Target: $14
Current: $1.22
Upside: +1,047.54%
GeoVax Labs
Sep 17, 2026
Reiterated: Buy
Price Target: $10
Current: $0.281
Upside: +3,458.72%
Unicycive Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $50
Current: $4.11
Upside: +1,116.55%
Nutriband
Aug 12, 2026
Reiterated: Buy
Price Target: $15
Current: $6.65
Upside: +125.56%
NeuroSense Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $180
Current: $3.66
Upside: +4,818.03%
Gyre Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $20
Current: $7.04
Upside: +184.09%
Cadrenal Therapeutics
Jul 14, 2026
Reiterated: Buy
Price Target: $45
Current: $0.9101
Upside: +4,844.51%
Jun 2, 2026
Reiterated: Buy
Price Target: $45
Current: $16.53
Upside: +172.23%
May 27, 2026
Reiterated: Buy
Price Target: $6 → $10
Current: $1.07
Upside: +834.58%
May 22, 2026
Reiterated: Buy
Price Target: $12
Current: $1.08
Upside: +1,011.11%
May 8, 2026
Reiterated: Buy
Price Target: $8
Current: $6.63
Upside: +20.66%
Mar 16, 2026
Reiterated: Buy
Price Target: $70 → $37
Current: $7.30
Upside: +406.85%
Jun 27, 2025
Rated: Hold
Price Target: n/a
Current: $0.082515
Upside: n/a
Feb 24, 2025
Rated: Hold
Price Target: n/a
Current: $1.38
Upside: n/a
Feb 24, 2025
Rated: Hold
Price Target: n/a
Current: $0.4452
Upside: n/a
Jan 21, 2025
Rated: Hold
Price Target: n/a
Current: $0.079875
Upside: n/a
Aug 16, 2022
Reiterated: Buy
Price Target: $5
Current: $2.72
Upside: n/a
Aug 15, 2022
Reiterated: Buy
Price Target: $8 → $9
Current: $0.994
Upside: n/a
Jun 1, 2022
Reiterated: Buy
Price Target: $0.72
Current: $0.04
Upside: n/a
May 14, 2021
Reiterated: Buy
Price Target: $20 → $20
Current: $1.49
Upside: n/a
Feb 9, 2021
Reiterated: Buy
Price Target: $18 → $27
Current: $0.000001
Upside: n/a
Jan 26, 2021
Reiterated: Buy
Price Target: $6 → $15
Current: $4.33
Upside: n/a
Jan 25, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $1.93
Upside: n/a
Jan 24, 2021
Reiterated: Buy
Price Target: $6 → $14
Current: $1.55
Upside: n/a
Dec 28, 2020
Downgraded: Hold
Price Target: n/a
Current: $5.35
Upside: n/a
Dec 24, 2020
Reiterated: Buy
Price Target: $6
Current: $0.5989
Upside: n/a
Nov 12, 2020
Reiterated: Buy
Price Target: $8
Current: $0.000001
Upside: n/a
Oct 5, 2020
Downgraded: Hold
Price Target: n/a
Current: $8.87
Upside: n/a
May 28, 2020
Reiterated: Buy
Price Target: $5
Current: $4.79
Upside: n/a
Feb 18, 2020
Initiated Coverage: Buy
Price Target: $30
Current: $1.41
Upside: n/a
Nov 1, 2018
Rated: Hold
Price Target: n/a
Current: $2.51
Upside: n/a
Nov 1, 2018
Rated: Hold
Price Target: n/a
Current: $4.08
Upside: n/a
Apr 10, 2018
Downgraded: Hold
Price Target: $17 → $1
Current: $31.18
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $5.38
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $1.96
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $1.06
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $2.87
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 5, 2016
Downgraded: Hold
Price Target: $54 → $41
Current: $19.78
Upside: n/a